Rigel Pharmaceuticals, Inc. (RIGL)
NASDAQ: RIGL · Real-Time Price · USD
48.86
-0.02 (-0.04%)
Oct 22, 2026, 4:00 PM EDT - Market closed
Rigel Pharmaceuticals Market Cap
Rigel Pharmaceuticals has a market cap or net worth of $912.7 million as of October 22, 2026. It is the 10,487th most valuable company in the world and the 2,297th biggest in the United States. Its market cap has increased by 68.08% in one year.
Market Cap
912.70M
Enterprise Value
857.32M
1-Year Change
68.08%
Global Rank
Country Rank
#2,297 United States
Category
ChartMarket Cap Chart
Since November 29, 2000, Rigel Pharmaceuticals's market cap has increased from $254.90M to $912.70M, an increase of 258.06%. That is a compound annual growth rate of 5.05%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2026 | 912.70M | 17.40% |
| Dec 31, 2025 | 777.40M | 162.37% |
| Dec 31, 2024 | 296.30M | 17.21% |
| Dec 29, 2023 | 252.80M | -2.51% |
| Dec 30, 2022 | 259.30M | -42.78% |
| Dec 31, 2021 | 453.20M | -23.37% |
| Dec 31, 2020 | 591.40M | 64.87% |
| Dec 31, 2019 | 358.70M | -6.42% |
| Dec 31, 2018 | 383.30M | -32.57% |
| Dec 29, 2017 | 568.40M | 141.36% |
| Dec 30, 2016 | 235.50M | -12.19% |
| Dec 31, 2015 | 268.20M | 34.57% |
| Dec 31, 2014 | 199.30M | -20.02% |
| Dec 31, 2013 | 249.20M | -55.93% |
| Dec 31, 2012 | 565.50M | 0.60% |
| Dec 30, 2011 | 562.10M | 43.14% |
| Dec 31, 2010 | 392.70M | -20.31% |
| Dec 31, 2009 | 492.80M | 68.36% |
| Dec 31, 2008 | 292.70M | -62.86% |
| Dec 31, 2007 | 788.20M | 164.67% |
| Dec 29, 2006 | 297.80M | 47.43% |
| Dec 30, 2005 | 202.00M | -57.71% |
| Dec 31, 2004 | 477.70M | 68.26% |
| Dec 31, 2003 | 283.90M | 465.54% |
| Dec 31, 2002 | 50.20M | -71.28% |
View and export this data all the way back to 2000. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Jade Biosciences | 945.06M |
| ArriVent BioPharma | 929.45M |
| Odyssey Therapeutics | 909.97M |
| Aktis Oncology | 894.36M |
| Kura Oncology | 887.83M |
| MoonLake Immunotherapeutics | 878.30M |
| SpyGlass Pharma | 872.66M |
| Alumis | 867.22M |